Clinical, Genetic, and Endocrine Features of Bardet‐Biedl Syndrome in a Pediatric and Adult Cohort
Authors:
- Doha HassanDHDoha Hassan
- Mostafa SalamaMSMostafa Salama
- Kalpana MuthusamyKMKalpana Muthusamy
- Brittni A. ScruggsBSBrittni A. Scruggs
- Brendan C. LanpherBLBrendan C. Lanpher
- Quennie K. G. TanQTQuennie K. G. Tan
- Carl H. CramerCCCarl H. Cramer
- Bridget BiggsBBBridget Biggs
- Amy E. RabatinARAmy E. Rabatin
- Afton KoballAKAfton Koball
- 13 August 2026
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
Abstract
Bardet‐Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by clinical and genetic heterogeneity. Data on the prevalence of clinical manifestations and comorbidities in BBS, particularly in pediatric patients, are limited. This study aimed to assess the prevalence and various manifestations of endocrine and other clinical comorbidities among pediatric and adult patients with BBS. This retrospective chart review included pediatric and adult patients with BBS evaluated at an academic tertiary care center in the United States between 2000 and 2024. The study included 31 patients (7 children and 24 adults) with seven identified pathogenic variants associated with BBS. The most common genetic etiology was biallelic variants in BBS1 (36%). Obesity was diagnosed in 86% of children and 100% of adults. No children had diabetes or prediabetes, whereas 46% of adults were affected. Dyslipidemia was identified in 29% of children and 46% of adults. No thyroid abnormalities were identified in children, whereas 25% of adults were affected. Retinal dystrophy was present in 71% of children and 96% of adults. Polydactyly was observed in 100% of children and 75% of adults. Chronic kidney disease was present in 29% of children and 63% of adults. This study highlights the clinical heterogeneity and substantial multisystem burden of BBS across pediatric and adult patients. The greater prevalence of diabetes/prediabetes, dyslipidemia, thyroid abnormalities, chronic kidney disease, and visual impairment among adults suggests that these complications may emerge or progress over time. Early recognition, proactive longitudinal surveillance, and comprehensive multidisciplinary care are essential to optimize management across the lifespan.Keywords
This publication has 42 references indexed in Scilit:
- Metabolic Dysfunction–Associated Steatotic Liver Disease in AdultsJAMA, 2026
- Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohortEuropean Journal of Pediatrics, 2025
- CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial EtiologyKidney International Reports, 2024
- Obesity Management in AdultsJAMA, 2023
- Exome sequencing in a Romanian Bardet‐Biedl syndrome cohort revealed an overabundance of causal BBS12 variantsAmerican Journal of Medical Genetics Part A, 2023
- Screening for High Blood Pressure in Children and AdolescentsJAMA, 2020
- Meta‐analysis of genotype‐phenotype associations in Bardet‐Biedl syndrome uncovers differences among causative genesHuman Mutation, 2019
- Ciliopathy: Bardet-Biedl Syndrome2018
- Renal transplantation in Bardet–Biedl SyndromePediatric Nephrology, 2016
- Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: A 22-year prospective, population-based, cohort studyAmerican Journal of Medical Genetics Part A, 2005